Strategic value often stops being tracked systematically after the funding round is done. TechNexus built a scoring tool that keeps it part of the ongoing portfolio reviews.

TECHNEXUS IS PROUD TO SUPPORT GCV: This piece has been produced as part of a content partnership
Sit in on a corporate venture investment committee meeting before a term sheet goes out, and you’ll hear a specific kind of conversation. Is the founding team strong enough to execute? Does this deal open a channel, a technology, or a capability our parent company couldn’t get any other way? The financial model is on the table too, but it alone doesn’t decide the room. A corporate writes the cheque because the strategic case is worth something beyond the multiple.
But when the deal closes, somewhere between the term sheet and the first quarterly business review, that strategic thinking quietly leaves the room.
The review that only remembers half the deal
Ask most corporate venture teams how a portfolio company is performing, and the answer comes back financial: revenue growth, burn, runway. None of it answers the question that justified the investment in the first place — is the strategic relationship actually working?
This isn’t because CVC teams stopped caring about strategic value. It’s because nobody built a way to track it with the same rigor as the financials. Revenue has a line item. Strategic value doesn’t. So when a portfolio review gets assembled, the things that are easy to measure crowd out the thing that was actually the point — and the cost shows up at the worst moment.
When a CFO turns over, when budgets tighten, when someone on the board asks what the venture portfolio is actually worth, “we like the founders’ grit” isn’t an answer an audit committee will accept. A portfolio that can’t defend its strategic value in the same language as everything else on the balance sheet is one budget cycle away from being the easiest thing to cut.
It’s a problem we at TechNexus have seen first-hand. Working side-by-side with corporations to manage their venture operations, we’ve seen how quickly strategic value gets thrown out the window during portfolio review. And if it does come up, we had no way of quantifying just how strategic a venture has become to the corporation.
To fix this, I started to conceptualise a way to combine qualitative and quantitative data into a digestible grade. Working as part of our Venture Operations team we turned it into an AI-powered product called PRIME/X.
Meet PRIME/X
PRIME/X scores every company in a venture portfolio on whether it is on rack to execute its plan and exit successfully. It looks at all the factors that a venture capital investor would track:
- Performance (revenue, margins, cash runway)
- Return profile (MOIC, cap table seniority, vintage)
- Influence (founding team, leadership, board)
- Market conditions (competitive position, sector dynamics)
- Engagement (customer pipeline, strategic partnerships).
The sixth measure is the X-Factor, and it’s built for a question only corporate venture teams need to answer: is this partnership actually making the parent company stronger, and positioning the venture unit for success?
We score it, like every other dimension, against sourced evidence rather than impression — across four things:
- can the collaboration win the corporate partner new customers,
- open a new revenue stream,
- save it R&D spend it would otherwise carry,
- or improve its operating efficiency.
Each of those four gets tested against what the relationship has actually produced — an active relationship, pilots run, introductions made, meetings held in the last twelve months — not against what the original thesis assumed would happen. Most corporate venture relationships are underused relative to their potential on at least one of those four levers, and without a structured way to track which ones, that unrealised value simply doesn’t register.
Plotted against the other five PRIME dimensions, the X-Factor shows where strategic value and financial performance are moving together — and where they’re pulling apart. It’s one of the clearest patterns PRIME/X has surfaced since we put it into practice across our own portfolio.
For instance: we recently reviewed two companies in our portfolio with similar financials — both growing revenue at a healthy clip, both inside their runway targets — that a purely financial review would have ranked the same. The X-Factor separated them immediately.
One had a pilot that never scaled past a single business unit, no meeting between the teams in over a year, and a roadmap that had drifted away from the partner’s priorities — it was a sound investment that had quietly stopped delivering on the primary reason it was funded. The other had a live commercial agreement generated directly from the partnership and a pilot that had turned into a referral pipeline the corporate wouldn’t have built on its own. Same financial profile, opposite strategic trajectory.
A metric, not a memory
Here’s what any corporate venture team rebuilding its portfolio review process should consider: you already know how to evaluate strategic value. You did it, carefully, before every cheque you wrote. The discipline doesn’t need to be invented, but it needs to survive the closing of the deal, treated as a metric and not a memory, so a board can be told in specific terms what a company has delivered strategically and what remains on the table.
Corporate venture was never supposed to be venture capital with a strategic label attached. It was supposed to be a different discipline, built around a different kind of return. PRIME/X — and the X-Factor specifically — is our attempt to give that discipline the rigour it was always missing.
Ellie Schweska is the Director of Venture Operations at TechNexus Venture Collaborative, which manages more than $300M for corporate partners across 250-plus investments. She is also on the founding team for SecondWave, TechNexus’ portfolio management service for corporate venture portfolios. If you are designing or rethinking your portfolio review processes or want to discuss an alternative approach to corporate venturing, get in touch here.
